--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
US Stock MarketDetailed Quotes
TYPTF TRYPTAMINE THERAPEUTICS LIMITED
- 0.020
- +0.015+292.16%
15min DelayClose Oct 4 16:00 ET
23.78MMarket Cap-769P/E (TTM)
0.020High0.018Low6.10KVolume0.020Open0.005Pre Close116.00Turnover0.00%Turnover RatioLossP/E (Static)1.19BShares0.02052wk High6.67P/B23.78MFloat Cap0.00152wk Low--Dividend TTM1.19BShs Float0.020Historical High--Div YieldTTM39.22%Amplitude0.001Historical Low0.019Avg Price1Lot Size
TRYPTAMINE THERAPEUTICS LIMITED Key Stats
TRYPTAMINE THERAPEUTICS LIMITED Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CAD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
